Emerging role of the cannabinoid receptor CB 2 in immune regulation: therapeutic prospects for neuroinflammation

The capsaicin receptor: a heat-activated ion channel in the pain pathway

Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. J. (1997) · Nature · doi:10.1038/39807 · Cited by 9,132

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011

Microglia: a sensor for pathological events in the CNS

Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396

Cell Migration: A Physically Integrated Molecular Process

Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

The many roles of chemokines and chemokine receptors in inflammation

Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321

Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,232

Human Chemokines: An Update

Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,193

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,776

lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines

Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,672

The cell biology of macrophage activation.

Adams, D. O., & Hamilton, T. A. (1984) · Annual Review of Immunology · doi:10.1146/annurev.iy.02.040184.001435 · Cited by 1,628

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585

The orphan receptor GPR55 is a novel cannabinoid receptor

Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568

Actin-Based Cell Motility and Cell Locomotion

Mitchison, T. J., & Cramer, L. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81281-7 · Cited by 1,538

Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470

Brain monoglyceride lipase participating in endocannabinoid inactivation

Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373

Characterization of ameboid microglia isolated from developing mammalian brain

Giulian, D., & Baker, T. J. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02163.1986 · Cited by 1,300

Acanthamoeba spp. as Agents of Disease in Humans

Marciano‐Cabral, F., & Cabral, G. A. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.273-307.2003 · Cited by 1,293

N-formylmethionyl peptides as chemoattractants for leucocytes.

Schiffmann, E., Corcoran, B. A., & Wahl, S. M. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.1059 · Cited by 889

The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease

Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862

Chemokine receptors and their role in inflammation and infectious diseases

Murdoch, C., & Finn, A. H. R. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 844

Cannabinoid CB2 receptors: immunohistochemical localization in rat brain

Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820

Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition

Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813

Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & CEBALLOS, M. L. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 801

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775

PLATELET ACTIVATING FACTOR: A BIOLOGICALLY ACTIVE PHOSPHOGLYCERIDE

Hanahan, D. J. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.002411 · Cited by 774

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 732

Cannabinoid-based drugs as anti-inflammatory therapeutics

Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728 · cited 10×

Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration

Walter, L. M., Franklin, A., Witting, A., Wade, C. B., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 674

Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 636

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., & Leon, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3376 · Cited by 632

Anandamide and vanilloid TRPV1 receptors

Ross, R. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705467 · Cited by 603

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. M., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, É., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 597

Presynaptic Inhibition Caused by Retrograde Signal from Metabotropic Glutamate to Cannabinoid Receptors

Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00375-0 · Cited by 575

Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain

Onaivi, E. S., Ishiguro, H., GONG, J., Sejal, P., Perchuk, A., Meozzi, P. A., MYERS, L., Mora, Z., Tagliaferro, P. A., Gardner, E., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.052 · Cited by 564

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor

Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T. I., Zimmer, A. M., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 546

Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain

Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 538

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 532

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509

Modulation of the cannabinoid CB 2 receptor in microglial cells in response to inflammatory stimuli

Maresz, K., Carrier, E. J., Ponomarev, E. D., Hillard, C. J., & Dittel, B. N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03380.x · Cited by 490

Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.

Howlett, A. C., Qualy, J. M., & Khachatrian, L. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10219-8 · Cited by 470

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Steffens, S., Veillard, N. R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Zimmer, A. D., Frossard, J., & Mach, F. (2005) · Nature · doi:10.1038/nature03389 · Cited by 469

Cannabinoid signalling

Demuth, D. G., & Molleman, A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.055 · Cited by 435

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419

C5A Anaphylatoxin and Its Seven Transmembrane-Segment Receptor

Gerard, C. J., & Gerard, N. P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.004015 · Cited by 417

Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

Marzo, V. D., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 394

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

Ehrhart, J. C., Obregon, D. F., Mori, T., Hou, H., Sun, N., Bai, Y., Klein, T., Fernandez, F., Tan, J., & Shytle, R. D. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-29 · Cited by 386

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, ΨGPR53 and GPR55: GPR55 is extensively expressed in human brain

Sawzdargo, M., Nguyen, T., Lee, D. K., Lynch, K. R., Cheng, R., Heng, H. H., George, S. R., & O’Dowd, B. F. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00277-0 · Cited by 378

Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.

Howlett, A. C., & Fleming, R. M. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15066-9 · Cited by 376

Cannabinoid‐receptor expression in human leukocytes

Bouaboula, M., Rinaldi, M. L., CARAYON, P., Carillon, C., Delpech, B., Shire, D. J., Fur, G. L., & Casellas, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17910.x · Cited by 376

Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques

Williams, K. C., Corey, S. M., Westmoreland, S. V., Pauley, D. R., Knight, H., deBakker, C. D., Alvarez, X. A., & Lackner, A. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.905 · Cited by 371

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

Fernández‐Ruíz, J., Romero, J., Velasco, G., Tolón, R. M., Ramos, J. A., & Guzmán, M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.11.001 · Cited by 362

CB2receptors in the brain: role in central immune function

Cabral, G. A., Raborn, E. S., Griffin, L., Dennis, J., & Marciano‐Cabral, F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707584 · Cited by 361

Cannabinoid Receptors CB1 and CB2: A Characterization of Expression and Adenylate Cyclase Modulation within the Immune System

Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., & Kaminski, N. E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8034 · Cited by 359

In silico patent searching reveals a new cannabinoid receptor

Baker, D., Pryce, G., Davies, W. I. L., & Hiley, C. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 347

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

Carlisle, S. J., Marciano‐Cabral, F., Staab, A., LUDWICK, C., & Cabral, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00147-3 · Cited by 347

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study

Núñez, E., Benito, C., Pazos, M. R., Barbáchano, A., Fajardo, O., González, S. R., Tolón, R. M., & Romero, J. (2004) · Synapse · doi:10.1002/syn.20050 · Cited by 346

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration

Ashton, J. C., & Glass, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866884 · Cited by 342

Cultured Rat Microglial Cells Synthesize the Endocannabinoid 2-Arachidonylglycerol, Which Increases Proliferation via a CB2 Receptor-Dependent Mechanism

Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant

Shohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben‐Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 332

Motor neuron disease.

Leigh, P. N., & Chaudhuri, К. R. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.886 · Cited by 329

Molecular mechanisms of signal transduction in macrophages

Hamilton, T. A., & Adams, D. O. (1987) · Immunology Today · doi:10.1016/0167-5699(87)90145-9 · Cited by 327

A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation

Dinh, T. P., Freund, T. F., & Piomelli, D. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00150-0 · Cited by 319

Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis

Arévalo‐Martín, Á., Vela, J. M., Molina‐Holgado, E., Borrell, J. I., & Guaza, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02511.2003 · Cited by 316

Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.

Le, Y., Zhou, Y., Iribarren, P., & Wang, J. (2004) · PubMed · Cited by 304

Biosynthesis and inactivation of the endocannabinoid 2‐arachidonoylglycerol in circulating and tumoral macrophages

Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296

Signaling Pathway Associated with Stimulation of CB2 Peripheral Cannabinoid Receptor

Bouaboula, M., Poinot‐Chazel, C., Marchand, J., Canat, X., Bourrié, B., Rinaldi, M. L., Calandra, B., Fur, G. L., & Casellas, P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0704p.x · Cited by 290

Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains

Westlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A., & Herkenham, M. A. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90511-8 · Cited by 290

Multiple Sclerosis: Remyelination in Acute Lesions

Raine, C. S., & WU, E. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199305000-00003 · Cited by 285

Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids.

Lynn, A. B., & Herkenham, M. A. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38654-4 · Cited by 278

Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.

Goldman, D. W., & Goetzl, E. J. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1600 · Cited by 259

Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.

Howlett, A. C. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12377-8 · Cited by 257

Cannabinoid CB1and CB2Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis

Benito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., & Romero, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-06.2007 · Cited by 256

Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway

Zhu, L. X., Sharma, S. P., Stolina, M., Gardner, B. K., Roth, M. D., Tashkin, D. P., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.373 · Cited by 252

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor

Klegeris, A., Bissonnette, C. J., & McGeer, P. L. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705304 · Cited by 251

Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells

Puffenbarger, R. A., Boothe, A. C., & Cabral, G. A. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1 · Cited by 248

GPR55: a new member of the cannabinoid receptor clan?

Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707464 · Cited by 247

Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.

Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., & Schatz, A. R. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09130-8 · Cited by 246

Synthetic cannabinoid WIN55,212‐2 inhibits generation of inflammatory mediators by IL‐1β‐stimulated human astrocytes

Sheng, W. S., Hu, S., Min, X. M., Cabral, G. A., Lokensgard, J. R., & Peterson, P. K. (2004) · Glia · doi:10.1002/glia.20108 · Cited by 246

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance

Cabral, G. A., & Marciano‐Cabral, F. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405216 · Cited by 241

Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system

Williams, K. C., Alvarez, X. A., & Lackner, A. A. (2001) · Glia · doi:10.1002/glia.1105 · Cited by 237

Cannabinoid receptors and immunity

Klein, T., Newton, C. A., & Friedman, H. P. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 235

Cellular signal transduction by anandamide and 2-arachidonoylglycerol

Howlett, A. C., & Mukhopadhyay, S. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00187-0 · Cited by 229

The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells

Waksman, Y., Olson, J. M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38093-0 · Cited by 227

The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling

Bayewitch, M. L., Avidor‐Reiss, T., Levy, R., Barg, J., Mechoulam, R., & Vogel, Z. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01207-u · Cited by 215

The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

Shoemaker, J. L., Seely, K. A., Reed, R. L., Crow, J. P., & Prather, P. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04346.x · Cited by 212

Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor

Griffin, G., Tao, Q., & Abood, M. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35367-4 · Cited by 210

Cloning and molecular characterization of the rat CB2 cannabinoid receptor

Brown, S. M., Wager‐Miller, J., & Mackie, K. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00341-x · Cited by 201

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

Croxford, J. L., & Miller, S. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17652 · Cited by 197

Role of Chemotaxis in Inflammation

Harris, H. (1954) · Physiological Reviews · doi:10.1152/physrev.1954.34.3.529 · Cited by 192

Marijuana, immunity and infection

Klein, T., Friedman, H., & Specter, S. C. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00226-9 · Cited by 191

Neuropsychobiological Evidence for the Functional Presence and Expression of Cannabinoid CB2 Receptors in the Brain

Onaivi, E. S. (2006) · Neuropsychobiology · doi:10.1159/000100778 · Cited by 191

Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.

Slipetz, D. M., O’Neill, G. P., Favreau, L., Dufresne, C., Gallant, M., Gareau, Y., Guay, D., Labelle, M., & Metters, K. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10254-x · Cited by 191

Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.

Jeon, Y. J., Yang, K. H., Pulaski, J. T., & Kaminski, N. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09237-5 · Cited by 190

Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors

Melck, D., Bisogno, T., De Petrocellis, L., Chuang, H.-H., Julius, D., Bifulco, M., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1105 · Cited by 188

Modulation and Functional Involvement of CB2 Peripheral Cannabinoid Receptors During B-Cell Differentiation

Carayon, P., Marchand, J., Dussossoy, D., Derocq, J., Jbilo, O., Bord, A., Bouaboula, M., Galiègue, S., Mondière, P., Pénarier, G., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3605 · Cited by 179

Cannabinoids enhance human B‐cell growth at low nanomolar concentrations

Derocq, J., Ségui, M., Marchand, J., Fur, G. L., & Casellas, P. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00746-v · Cited by 168

The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking

Palazuelos, J., Davoust, N., Julien, B., Hatterer, E., Aguado, T., Mechoulam, R., Benito, C., Romero, J., Silva, A., Guzmán, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707960200 · Cited by 168

Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice

Bilsland, L. G., Dick, J. R. T., Pryce, G., Petrosino, S., Marzo, V. D., Baker, D., & Greensmith, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4743fje · Cited by 168

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

Dickson, D. W. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00065-1 · Cited by 168

Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

Berdyshev, E. V., Boichot, E., Germain, N., Allain, N., Anger, J.-P., & Lagente, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01007-8 · Cited by 168

Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes

Saario, S. M., Savinainen, J. R., Laitinen, J. T., Järvinen, T., & Niemi, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.003 · Cited by 167

A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis: Regulation of CXCL12 expression in astrocytes by soluble myelin basic protein

Calderon, T. M., Eugenín, E. A., Lopez, L., Kumar, S. S., Hesselgesser, J., Raine, C. S., & Berman, J. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.003 · Cited by 166

Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids

Öz, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.009 · Cited by 164

A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis

Benito, C., Kim, W.-K., Chavarría, I., Hillard, C. J., Mackie, K., Tolón, R. M., Williams, K., & Romero, J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3923-04.2005 · Cited by 164

Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol

Alberich-Jordà, M., Verbakel, S. E., Valk, P. J. M., Vankan, Y., Maccarrone, M., Finazzi-Agrò, A., Löwenberg, B., & Delwel, R. (2002) · Blood · doi:10.1182/blood.v99.8.2786 · Cited by 161

Vanilloid (Capsaicin) Receptors in Health and Disease

SZALLASI, A. (2002) · American Journal of Clinical Pathology · doi:10.1309/7ayy-vvh1-gqt5-j4r2 · Cited by 160

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

Croxford, J. L., & Miller, S. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317652 · Cited by 160

Δ9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-γ, IL-12, and IL-12 Receptor β2 Responses to Legionella pneumophila Infection

Klein, T., Newton, C. A., Nakachi, N., & Friedman, H. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6461 · Cited by 159

Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease

Cabral, G. A., & Pettit, D. A. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00227-0 · Cited by 151

Carrier-Mediated Uptake of the Endogenous Cannabinoid Anandamide in RBL-2H3 Cells

Rakhshan, F., Day, T. A., Blakely, R., & Barker, E. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35376-5 · Cited by 149

Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide‐induced nitric oxide release in astrocyte cultures

Molina‐Holgado, F., Molina‐Holgado, E., Guaza, C., & Rothwell, N. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10165 · Cited by 148

HUMAN IMMUNODEFICIENCY VIRUS AND THE CENTRAL NERVOUS SYSTEM

Spencer, D. C., & Price, R. W. (1992) · Annual Review of Microbiology · doi:10.1146/annurev.mi.46.100192.003255 · Cited by 140

Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection

Newton, C., Klein, T., & Friedman, H. P. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.4015-4020.1994 · Cited by 140

Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide

Day, T. A., Rakhshan, F., Deutsch, D. G., & Barker, E. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1369 · Cited by 139

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes

Joseph, J., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0509-9 · Cited by 137

Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism

Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., & Kessler, F. K. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90588-6 · Cited by 132

Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells

Zoratti, C., Kipmen‐Korgun, D., Osibow, K., Malli, R., & Graier, W. F. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705529 · Cited by 131

Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain

Ashton, J. C., Rahman, R. M. A., Nair, S. M., Sutherland, B. A., Glass, M., & Appleton, I. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.053 · Cited by 131

Advances in experimental medicine and biology

(1984) · International Journal of Biochemistry · doi:10.1016/0020-711x(84)90214-3 · Cited by 128

The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro

Sacerdote, P., Martucci, C., Vaccani, A., Bariselli, F., Panerai, A. E., Colombo, A., Parolaro, D., & Massi, P. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.003 · Cited by 126

2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism

Kishimoto, S., Gokoh, M., Oka, S., Muramatsu, M., Kajiwara, T., Waku, K., & Sugiura, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301359200 · Cited by 125

In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors

Sacerdote, P., Massi, P., Panerai, A. E., & Parolaro, D. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00307-6 · Cited by 124

Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!

Grimsey, N. L., Goodfellow, C. E., Scotter, E. L., Dowie, M. J., Glass, M., & Graham, E. S. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.02.014 · Cited by 123

Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus

Morahan, P. S., Klykken, P. C., Smith, S., Harris, L. S., & Munson, A. E. (1979) · Infection and Immunity · doi:10.1128/iai.23.3.670-674.1979 · Cited by 121

Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes

Ghosh, S. T., Preet, A., Groopman, J. E., & Ganju, R. K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.01.005 · Cited by 120

Cannabinoid Inhibition of the Processing of Intact Lysozyme by Macrophages: Evidence for CB2 Receptor Participation

McCoy, K. L., Matveyeva, M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38313-2 · Cited by 116

The peripheral cannabinoid receptor knockout mice: an update

Buckley, N. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707527 · Cited by 115

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation

Docagne, F., Muñetón‐Gómez, V. C., Clemente, D., Ali, C., Loría, F., Correa, F., Hernangómez, M., Mestre, L., Vivien, D., & Guaza, C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.12.005 · Cited by 109

Effects on the Immune System

Cabral, G. A., & Staab, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_13 · Cited by 108

Regulation of Peripheral Cannabinoid Receptor CB2Phosphorylation by the Inverse Agonist SR 144528

Bouaboula, M., Dussossoy, D., & Casellas, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20397 · Cited by 107

The endogenous cannabinoid anandamide potentiates interleukin‐6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor‐mediated pathway

Molina‐Holgado, F., Molina‐Holgado, E., & Guaza, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00851-5 · Cited by 106

Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor Is a Novel Synergistic Growth Factor for Hematopoietic Cells

Valk, P. J. M., Verbakel, S. E., Vankan, Y., Hol, S., Mancham, S., Ploemacher, R., Mayen, A. E. M., Löwenberg, B., & Delwel, R. (1997) · Blood · doi:10.1182/blood.v90.4.1448 · Cited by 105

Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival

Weydt, P., Hong, S. Y., Witting, A., Möller, T., Stella, N., & Kliot, M. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510030149 · Cited by 104

Drugs of abuse and immune function

WATSON, R. R. (1990) · CRC Press eBooks · Cited by 101

Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes

Wiley, J. L., & Martin, B. R. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00146-9 · Cited by 100

Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth

DeMorrow, S., Glaser, S. S., Francis, H., Venter, J. K., Vaculin, B. T., Vaculin, S., & Alpini, G. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608238200 · Cited by 100

Differential expression of cannabinoid CB2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation

Lee, S. F., Newton, C. A., Widen, R. E., Friedman, H. P., & Klein, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01122-0 · Cited by 100

Elevated Inflammatory Markers in a Group of Amyotrophic Lateral Sclerosis Patients from Northern India

Babu, G. N., Kumar, A., Chandra, R., Puri, S. K., Kalita, J., & Misra, U. K. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9564-x · Cited by 96

Chemokine-Chemokine Receptor Network in Immune Cell Trafficking

Kim, C. H. (2004) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008043339712 · Cited by 95

Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo

Klein, T., Kawakami, Y., Newton, C. A., & Friedman, H. P. (1991) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399109531496 · Cited by 94

2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, Induces Accelerated Production of Chemokines in HL-60 Cells

Kishimoto, S. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh063 · Cited by 88

Identification of Endocannabinoids and Related Compounds in Human Fat Cells

Gonthier, M., Hoareau, L., Festy, F., Matias, I., Valenti, M., Bès-Houtmann, S., Rouch, C., Silva, C. R. D., Chesne, S., d’Hellencourt, C. L., et al. (2007) · Obesity · doi:10.1038/oby.2007.581 · Cited by 84

New Perspectives in the Studies on Endocannabinoid and Cannabis: Abnormal Behaviors Associate With CB1 Cannabinoid Receptor and Development of Therapeutic Application

Fujiwara, M., & Egashira, N. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fmj04003x2 · Cited by 80

Tetrahydrocannabinol inhibition of macrophage nitric oxide production

Coffey, R. G., Yamamoto, Y., Snella, E. M., & Pross, S. H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00356-5 · Cited by 77

Relative involvement of cannabinoid CB1 and CB2 receptors in the Δ9-tetrahydrocannabinol-induced inhibition of natural killer activity

Massi, P., Fuzio, D., Viganò, D., Sacerdote, P., & Parolaro, D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00860-2 · Cited by 77

Lipids as bioeffectors in the immune system

Cabral, G. A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.013 · Cited by 75

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

Arévalo‐Martín, Á., García‐Ovejero, D., Gómez, O., Rubio‐Araiz, A., Navarro‐Galve, B., Guaza, C., Molina‐Holgado, E., & Molina‐Holgado, F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707466 · Cited by 75 · cited 1×

Endocannabinoids in Neuroimmunology and Stress

Carrier, E. J., Patel, S., & Hillard, C. J. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/156800705774933023 · Cited by 72

The Cannabinoid Delta-9-tetrahydrocannabinol Mediates Inhibition of Macrophage Chemotaxis to RANTES/CCL5: Linkage to the CB2 Receptor

Raborn, E. S., Marciano‐Cabral, F., Buckley, N. E., Martin, B. R., & Cabral, G. A. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9077-z · Cited by 69

Chemoattractant Receptor Signaling and the Control of Lymphocyte Migration

Kehrl, J. H. (2006) · Immunologic Research · doi:10.1385/ir:34:3:211 · Cited by 69

Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries

Gauthier, K. M., Baewer, D. V., Hittner, S. B., Hillard, C. J., Nithipatikom, K., Reddy, D. S., Falck, J. R., & Campbell, W. B. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00537.2004 · Cited by 66

2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1

Stefano, G. B., Bilfinger, T. V., Rialas, C. M., & Deutsch, D. G. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0702 · Cited by 64

Cannabinoid-mediated Inhibition of Inducible Nitric Oxide Production by Rat Microglial Cells: Evidence for CB1 Receptor Participation

Cabral, G. A., Harmon, K. W. N., & Carlisle, S. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_24 · Cited by 61

Distinct chemokinetic and chemotactic responses in neutrophil granulocytes

Keller, H. U., Wissler, J. H., Hess, M. W., & Cottier, H. (1978) · European Journal of Immunology · doi:10.1002/eji.1830080102 · Cited by 61

Effects of bacterial lipopolysaccharide on protein synthesis in murine peritoneal macrophages: Relationship to activation for macrophage tumoricidal function

Hamilton, T. A., Jansen, M., Somers, S. D., & Adams, D. O. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280103 · Cited by 58

R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the CB2 receptor

Sánchez, A., González-Pérez, P., Galve‐Roperh, I., & García‐Merino, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.018 · Cited by 56

Experimental Autoimmune Encephalomyelitis (EAE)

Racke, M. K. (2001) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0907s14 · Cited by 55

Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies

Sinha, D., Bonner, T. I., Bhat, N. R., & Matsuda, L. A. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00181-1 · Cited by 55

The endocannabinoid system modulates a transient TNF pathway that induces neural stem cell proliferation

Rubio‐Araiz, A., Arévalo‐Martín, Á., Gómez, O., Navarro‐Galve, B., García‐Ovejero, D., Suetterlin, P., Sánchez-Heras, E., Molina‐Holgado, E., & Molina‐Holgado, F. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.03.010 · Cited by 50

Immune control by endocannabinoids — New mechanisms of neuroprotection?

Ullrich, O., Merker, K., Timm, J., & Tauber, S. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.018 · Cited by 50

Distinct Expression Profiles of the Peripheral Cannabinoid Receptor in Lymphoid Tissues Depending on Receptor Activation Status

Rayman, N., Lam, K. H., Laman, J. D., Simons, P. J., Löwenberg, B., Sonneveld, P., & Delwel, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2111 · Cited by 49

Differential Inhibition of RAW264.7 Macrophage Tumoricidal Activity by 9Tetrahydrocannabinol

Burnette-Curley, D., & Cabral, G. A. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-210-43926 · Cited by 48

Cannabis and recurrent herpes simplex.

Juel‐Jensen, B. E. (1972) · BMJ · doi:10.1136/bmj.4.5835.296-a · Cited by 46

Cannabinoid-mediated exacerbation of brain infection by opportunistic amebae

Cabral, G. A., & Marciano‐Cabral, F. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.027 · Cited by 45

Delta-9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of bacillus calmétte-guérin-activated macrophages

Burnette-Curley, D., Marciano‐Cabral, F., Fischer‐Stenger, K., & Cabral, G. A. (1993) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(93)90048-4 · Cited by 41

Influence of Marijuana Components (THC and CBD) on Human Mononuclear Cell Cytokine Secretion In vitro

Watzl, B., Scuderi, P., & WATSON, R. R. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5925-8_7 · Cited by 39

Methanandamide increases COX‐2 expression and tumor growth in murine lung cancer

Gardner, B. K., Zhu, L. X., Sharma, S. P., Tashkin, D. P., & Dubinett, S. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0254fje · Cited by 39

Moving toward understanding eukaryotic chemotaxis

Jin, T., & Hereld, D. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.04.008 · Cited by 39

R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells: possible involvement of membrane lipid rafts

Hinz, B., Ramer, R., Eichele, K., Weinzierl, U., & Brune, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.095 · Cited by 36

Stimulated neutrophil locomotion: chemokinesis and chemotaxis.

Becker, E. L. (1977) · PubMed · Cited by 36

In vivo imaging of the brain cannabinoid receptor

Gifford, A. N., Makriyannis, A., Volkow, N. D., & Gatley, S. J. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00148-2 · Cited by 34

Delta‐9‐tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators

Cabral, G. A., & Mishkin, E. M. (1989) · Journal of Toxicology and Environmental Health · doi:10.1080/15287398909531243 · Cited by 34

EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors

Nowak, G., Arnt, J., & Hyttel, J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90621-8 · Cited by 28

Modulation of Interleukin 2 Activity by 9-Tetrahydrocannabinol after Stimulation with Concanavalin A, Phytohemagglutinin, or Anti-CD3 Antibody

Nakano, Y., Pross, S. H., & Friedman, H. P. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-201-43494c · Cited by 24

Immunosuppression by Marijuana and Components

Friedman, H. P., Klein, T., & Specter, S. C. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-043780-1.50041-5 · Cited by 22

Delta‐9‐Tetrahydrocannabinol (THC), the Major Psychoactive Component of Marijuana, Exacerbates Brain Infection by Acanthamoeba

Marciano‐Cabral, F., Ferguson, T., Bradley, S. G., & Cabral, G. A. (2001) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2001.tb00433.x · Cited by 21

Chemotaxis of monocytes.

Harris, H. (1953) · PubMed · Cited by 19

Downregulation of Cannabinoid Receptor 2 (CB2) Messenger RNA Expression During In Vitro Stimulation of Murine Splenocytes with Lipopolysaccharide

Lee, S. F., Newton, C. A., Widen, R. E., Friedman, H. P., & Klein, T. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_26 · Cited by 18

Tetrahydrocannabinol treatment suppresses growth restriction of Legionella pneumophila in murine macrophage cultures

Arata, S., Klein, T. W., Newton, C. A., & Friedman, H. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90590-8 · Cited by 18

Enhanced Growth of Legionella pneumophila in Tetrahydrocannabinol-Treated Macrophages

Arata, S., Newton, C., Klein, T., & Friedman, H. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-199-43330 · Cited by 16

Avoidance of Aβ[25-35] / (H2O2) -Induced Apoptosis in Lymphocytes by the Cannabinoid Agonists CP55, 940 and JWH-015 via Receptor-Independent and PI3K-Dependent Mechanisms: Role of NF- κB and p53

Velez‐Pardo, C., & Jiménez-Del-Río, M. (2006) · Medicinal Chemistry · doi:10.2174/157340606778250171 · Cited by 15

Diseases of the Nervous System.

(1935) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1935.02250130247018 · Cited by 14

Evidencias en favor de una pérdida axonal primaria en la esclerosis múltiple

Anthony, D. C., Hughes, P., & Perry, V. H. (2000) · Revista de Neurología · doi:10.33588/rn.3012.99548 · Cited by 10

Diseases of the Nervous System

Asbury, A. K., McKhann, G. M., McDonald, W. I., & Goadsby, P. J. (2004) · Cited by 7

Matrix Metalloproteinases Exhibit Different Expression Patterns in Inflammatory Demyelinating Diseases of the Central and Peripheral Nervous System

Kieseier, B. C., Clements, J. M., Gearing, A. J. H., & Hartung, H. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07729.x · Cited by 6

Amide Bond Bioisosteres: Strategies, Synthesis, and Successes

Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 692

CB2: a cannabinoid receptor with an identity crisis

Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 659

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

Marrs, W., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., Coy, J. W., Bodor, Á. L., Muccioli, G. G., Hu, S. S., Woodruff, G., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2601 · Cited by 460

Plant derived substances with anti-cancer activity: from folklore to practice

Fridlender, M., Kapulnik, Y., & Koltai, H. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00799 · Cited by 434

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs

Gamble, L.-J., Boesch, J. M., Frye, C. W., Schwark, W. S., Mann, S., Wolfe, L. M., Brown, H., Berthelsen, E. S., & Wakshlag, J. J. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00165 · Cited by 354

Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease

Basu, S., & Dittel, B. N. (2011) · Immunologic Research · doi:10.1007/s12026-011-8210-5 · Cited by 197

The CB2 receptor and its role as a regulator of inflammation

Turcotte, C., Blanchet, M., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 632

Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation

Rom, S., & Persidsky, Y. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9445-9 · Cited by 244

The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update

Rakotoarivelo, V., Mayer, T. Z., Simard, M., Flamand, N., & Marzo, V. D. (2024) · Molecules · doi:10.3390/molecules29143381 · Cited by 72

MICROGLIAL CELL EXPRESSION OF THE TYPE 2 CANNABINOID RECEPTOR REGULATES IMMUNE-MEDIATED NEUROINFLAMMATIONPreprint

Moe, A. B., Rayasam, A., Sauber, G., Shah, R. K., Yuan, C.-Y., Szabó, A., Moore, B. M., Colonna, M., Cui, W., Romero, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.10.552854